Profil
Thomas D.
Willis was the founder of ParAllele BioScience, Inc. since 2001, serving as Chief Scientific Officer from 2001 to 2013.
Dr. Willis is the founder of Sequenta, Inc. since 2007, serving as Chief Executive Officer.
Current jobs include Chief Executive Officer at Arima Genomics, Inc. since 2025 and Venture Partner at IIF Management Co. LLC since 2017.
Former jobs include Director at Boreal Genomics, Inc., Director at SpinX Technologies SA, Vice President-DNA Product Marketing at Affymetrix, Inc. in 2007, and Principal at Stanford Genome Technology Center from 1996 to 2013.
Education includes graduate and doctorate degrees from Stanford University and an undergraduate degree from Yale University.
Postes actifs de Thomas D. Willis
| Sociétés | Poste | Début |
|---|---|---|
Sequenta, Inc.
Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Directeur Général | 18/08/2010 |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2017 |
Arima Genomics Inc.
Arima Genomics Inc. BiotechnologyHealth Technology Engages in research, development and testing of cancer diagnostics | Directeur Général | 17/06/2025 |
Anciens postes connus de Thomas D. Willis
| Sociétés | Poste | Fin |
|---|---|---|
SpinX Technologies SA
SpinX Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment | Directeur/Membre du Conseil | 12/08/2010 |
| AFFYMETRIX, INC. | Sales & Marketing | 01/01/2007 |
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Develops and markets DNA and RNA purification, enrichment, and detection equipment and tools | Président | - |
Stanford Genome Technology Center | Corporate Officer/Principal | - |
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Directeur Général | - |
Formation de Thomas D. Willis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Commercial Services |
Sequenta, Inc.
Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Develops and markets DNA and RNA purification, enrichment, and detection equipment and tools | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpinX Technologies SA
SpinX Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment | Health Technology |
Stanford Genome Technology Center | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Arima Genomics Inc.
Arima Genomics Inc. BiotechnologyHealth Technology Engages in research, development and testing of cancer diagnostics | Health Technology |
















